Implementation and Preliminary Effectiveness of mHealth Apps for Improving Sickle Cell Disease Care during COVID-19: A Mixed-Methods Evaluation

Background: Sickle cell disease (SCD) is a chronic blood disorder, which disproportionately impacts Black individuals. Hydroxyurea therapy prevents SCD-related complications; yet it is underutilized, which contributes to further health inequities. Mobile health (mHealth) apps for patients and provid...

Descripción completa

Detalles Bibliográficos
Autores principales: Badawy, Sherif M., DiMartino, Lisa, Brambilla, Donald, Baumann, Ana, Burns, Ebony, Demartino, Theresa, Jacobs, Sara, Khan, Hamda, Klesges, Lisa, Kutlar, Abdullah, Nwosu, Chinonyelum, Shah, Nirmish, Hankins, Jane S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology. Published by Elsevier Inc. 2021
Materias:
904.Outcomes Research-Non-Malignant Conditions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701539/
http://dx.doi.org/10.1182/blood-2021-146411

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701539/
http://dx.doi.org/10.1182/blood-2021-146411

Ejemplares similares